Health In Tech demonstrated strong Q3 2025 performance with significant revenue acceleration and growth in key operational metrics, driven by expanding distribution channels and new product capabilities.
Total revenues reached $8.5 million, up 90% year over year.
positiveNine-month revenue of $25.8 million, representing 132% of full-year 2024 total revenue.
positiveAdjusted EBITDA was $1.0 million, an increase of 49% year over year.
positiveBilled enrolled employees increased by 7,654 year over year to 25,248.
positiveNumber of distribution partners (Brokers, TPAs, Agencies) expanded 57% year over year to 849.
positivePre-tax income was $0.6 million, up 48% year over year.
positiveGross margin decreased from 78.0% in Q3 2024 to 60.6% in Q3 2025.
attentionResearch and development expenses decreased significantly by 87% year over year, potentially impacting future innovation.
attentionAccounts receivable balance decreased by $0.1 million year over year, which could indicate slower collections or reduced sales in certain areas.
attentionMargin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.
Revenue growth reflects the continued expansion of our broker, TPA, and agency network, translating into sustained revenue momentum.
Launched large-employer underwriting within eDIYBS, extending speed and scalability into the mid- and large-employer market.
Exploring blockchain-enabled solutions for claims administration with AlphaTON Capital to modernize the process.
Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.
Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.